ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Offering Documents”) in connection with the Company’s February 8, 2024 initial public offering ("IPO"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, ...